FdaApplication
ANDA 211813
Identifiers
- fda_app_no: ANDA211813
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD |
| application_type | ANDA |
| approval_date | 2022-10-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LINEZOLID | LINEZOLID | 100MG/5ML | FOR SUSPENSION;ORAL |
1 product